New COVID-19 test could be game changer

NCPA August 28, 2020

On Aug. 26, the FDA authorized a new point-of-care antigen test that does not require an analyzer. The Abbott BinaxNOW test utilizes a nasal swab sample and delivers results in 15 minutes. NCPA is working with Abbott to ensure pharmacy access. As a reminder, in order to do point-of-care testing you need to have a CLIA Certificate of Waiver. Watch this how-to video to apply for one today. For more information on all things COVID-19 related, visit ncpa.org/coronavirus-information.

NCPA